Strict steps and conditions were recommended to ensure reliable data, including maintaining the correct alkali-to-FCR volume ratio, optimal reaction time and temperature, monitoring absorbance at 765 nm, and using gallic acid as a reference standard
week 10: 243.47 (26.31)) in subjects treated with a GSSG-containing lotion measured with a Mexameter MX18 (Courage + Khazaka Electronic GmbH, Germany)
10.1016/j.cellimm.2004.12.001 26
A further dimension emerged in May 2026, when the ATTAIN-MAINTAIN trial, published in Nature Medicine , found that patients who switched to orforglipron after achieving substantial weight loss on injectable GLP-1s maintained approximately 7580% of that weight reduction
Challenges and Countermeasures Safety assessment: Long term toxicity testing ( 6 months) is required to clarify carcinogenicity and reproductive toxicity
Can GLP-1 receptor agonists be delivered through the skin at all